Impact Of Data Concerns In Neurological Clinical Trials: Why Quality Matters
By Dr. Alan Kott, Practice Leader for Data Analytics, Signant Health

In the intricate and highly regulated realm of clinical trials—especially those targeting neurological conditions—the quality of data collected plays a pivotal role in determining the success or failure of a study. Despite meticulous trial design and rigorous statistical planning by researchers, data-related issues frequently emerge, which pose significant threats to the reliability and interpretability of outcomes. These concerns can range from inconsistencies in data collection methods to missing or inaccurate entries, all of which can compromise the integrity of the trial. Therefore, a deep understanding of potential data pitfalls, coupled with the implementation of robust strategies to mitigate them, is essential.
Explore how ensuring high data quality strengthens the validity of your findings and enhances the credibility of the research, ultimately contributing to better clinical decision-making and patient outcomes.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Supply Leader? Subscribe today.